Caren van Roekel

249 Use of an anti-reflux catheter in 166 Ho-radioembolization REFERENCES 1. Van Cutsem E, Cervantes A, Adam R, Sobrero A, Van Krieken JH, Aderka D, et al. ESMO consensus guidelines for the management of patients with metastatic colorectal cancer. Ann Oncol. 2016;27(8):1386-422. 2. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA. 2019;69(1):7-34. 3. Tirumani SH, Kim KW, Nishino M, Howards SA, Krajewski KM, Jagannathan JP, et al. Update on the Role of Imaging in Management of Metastatic Colorectal Cancer. Radiographics. 2014;34:1908-28. 4. Boas FE, Bodei L, Sofocleous CT. Radioembolization of Colorectal Liver Metastases: Indications, Technique, and Outcomes. J Nucl Med. 2017;58(Suppl 2):104S-11S. 5. van den Hoven AF, Lam MG, Jernigan S, van den Bosch MA, Buckner GD. Innovation in catheter design for intra- arterial liver cancer treatments results in favorable particle-fluid dynamics. J Exp Clin Cancer Res. 2015;34:74. 6. van den Hoven AF, Prince JF, Samim M, Arepally A, Zonnenberg BA, Lam MG, et al. Posttreatment PET-CT-confirmed intrahepatic radioembolization performed without coil embolization, by using the antireflux Surefire Infusion System. Cardiovasc Interv Radiol. 2014;37(2):523-8. 7. Rose SC, Kikolski SG, Chomas JE. Downstream hepatic arterial blood pressure changes caused by deployment of the surefire antireflux expandable tip. Cardiovasc Interv Radiol. 2013;36(5):1262-9. 8. Rose SC, Narsinh KH, Newton IG. Quantification of Blood Pressure Changes in the Vascular Compartment When Using an Anti-Reflux Catheter during Chemoembolization versus Radioembolization: A Retrospective Case Series. J Vasc IntervRadiol. 2017;28(1):103-10. 9. Arepally A, Chomas J, KraitchmanD, Hong K. Quantificationandreductionofrefluxduring embolotherapy using an antireflux catheter and tantalummicrospheres: ex vivoanalysis. J Vasc Interv Radiol. 2013;24(4):575-80. 10. Rose SC, Narsinh KH, Isaacson AJ, Fischman AM, Golzarian J. The Beauty and Bane of Pressure-Directed Embolotherapy: Hemodynamic Principles and Preliminary Clinical Evidence. Am J Roentgenol. 2019;212(3):686-95. 11. Pasciak AS, McElmurray JH, Bourgeois AC, Heidel RE, Bradley YC. The impact of an antireflux catheter on target volume particulate distribution in liver-directed embolotherapy: a pilot study. J Vasc Interv Radiol. 2015;26(5):660-9. 12. Smits MLJ, Dassen MG, Prince JF, Braat A, Beijst C, Bruijnen RCG, et al. The superior predictive value of ( 166 )Ho-scout compared with(99m)Tc-macroaggregatedalbuminprior to( 166 )Ho-microspheresradioembolization in patientswith livermetastases.EurJNuclMed Mol Im. 2020;47(4):798-806. 13. SmitsML, ElschotM, vandenBoschMA, van deMaat GH, van het Schip AD, Zonnenberg BA, et al. In vivo dosimetry based on SPECT andMR imaging of 166 Ho-microspheres for treatment of liver malignancies. J Nucl Med. 2013;54(12):2093-100. 9